President Donald Trump signs an executive order reducing the core childhood vaccines recommended by the federal government, prompting a reshaping of immunisation policy and sparking debate between medical authorities and policymakers.
President Donald Trump has signed an executive order that sharply narrows the childhood vaccines the federal government recommends for all children and pushes several others into a shared decision-making category between parents and clinicians, marking the latest step in a broader overhaul of US immunisation policy. The White House said the order, signed on August 10, keeps 11 vaccines on the core list, including those against measles, mumps, rubella, polio and HPV, while also directing federal agencies to revisit how shots are timed, sequenced and combined.
The move builds on a series of changes that began with a presidential memorandum in December 2025 and continued with a May order directing health officials to compare the US schedule with those used in peer nations. In January, the Department of Health and Human Services already shifted several vaccines, including influenza, COVID-19 and rotavirus, towards shared decision-making, while saying the revised framework was meant to reflect international practice and improve confidence in the schedule.
The August order goes further by urging the Department of Health and Human Services to develop single-antigen alternatives to combination vaccines and to explore changes to adjuvants, the ingredients added to some vaccines to strengthen the immune response. It also tells states to reconsider school-entry immunisation laws in light of the federal changes and directs the attorney general to challenge state rules that it says conflict with parental authority, religious liberty and disability-accommodation obligations.
The policy shift lands at a delicate moment for pharmacists and other providers, who often rely on the federal schedule when deciding what they can administer and bill for. In July, the American Pharmacists Association and eight partner organisations warned Robert F. Kennedy Jr. that a revised vaccine advisory process could slow recommendations that pharmacies depend on for scope of practice and reimbursement, noting that pharmacies delivered the majority of adult flu, RSV and COVID-19 vaccines last season.
Pediatric groups are taking a different path. The American Academy of Pediatrics on Monday issued its own influenza guidance for the 2026-27 season, recommending flu vaccination for all children 6 months and older and saying last season led to 190 paediatric deaths. The academy said coverage remained low and argued that independent guidance is needed because federal recommendations have become less predictable, underscoring the widening split between the White House and mainstream medical organisations over childhood vaccine policy.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.
